Publisher: Elsevier

Related content
Volume 11, Number 17, 3 September 2001

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Graphical Abstracts
pp. xi-xxii(12)

Favourites:Add to Favourites
Favourites:Add to Favourites

Evolution of anti-HIV drug candidates. Part 1: From α-Anilinophenylacetamide (α-APA) to imidoyl thiourea (ITU)
pp. 2225-2228(4)
Authors: Ludovici, D.W.; Kukla, M.J.; Grous, P.G.; Krishnan, S.; Andries, K.; de Bethune, M.; Azijn, H.; Pauwels, R.; de Clercq, E.; Arnold, E.; Janssen, P.A.J.

Favourites:Add to Favourites

Evolution of Anti-HIV Drug CandidatesPart 2: Diaryltriazine (DATA) Analogues
pp. 2229-2234(6)
Authors: Ludovici, D.W.; Kavash, R.W.; Kukla, M.J.; Ho, C.Y.; Ye, H.; de Corte, B.L.; Andries, K.; de Bethune, M.; Azijn, H.; Pauwels, R.; Moereels, H.E.L.; Heeres, J.; Koymans, L.M.H.; de Jonge, M.R.; van Aken, K.J.A.; Daeyaert, F.F.D.; J. Lewi, P.; Das, K.; Arnold, E.; Janssen, P.A.J.

Favourites:Add to Favourites

Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues
pp. 2235-2239(5)
Authors: Ludovici, D.W.; de Corte, B.L.; Kukla, M.J.; Ye, H.; Ho, C.Y.; Lichtenstein, M.A.; Kavash, R.W.; Andries, K.; de Bethune, M.; Azijn, H.; Pauwels, R.; Lewi, P.J.; Heeres, J.; Koymans, L.M.H.; de Jonge, M.R.; van Aken, K.J.A.; Daeyaert, F.F.D.; Das, K.; Arnold, E.; Janssen, P.A.J.

Favourites:Add to Favourites

Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents
pp. 2241-2244(4)
Authors: Seefeld, M.A.; Miller, W.H.; Newlander, K.A.; Burgess, W.J.; Payne, D.J.; Rittenhouse, S.F.; Moore, T.D.; deWolf, W.E.; Keller, P.M.; Qiu, X.; Janson, C.A.; Vaidya, K.; Fosberry, A.P.; Smyth, M.G.; Jaworski, D.D.; Slater-Radosti, C.; Huffman, W.F.

Favourites:Add to Favourites

The mechanism of action of bacimethrin, a naturally occurring thiamin antimetabolite
pp. 2245-2248(4)
Authors: Reddick, J.J.; Saha, S.; Lee, J.; Melnick, J.S.; Perkins, J.; Begley, T.P.

Favourites:Add to Favourites

Synthesis and microtubule binding of fluorescent paclitaxel derivatives
pp. 2249-2252(4)
Authors: Baloglu, E.; Kingston, D.G.I.; Patel, P.; Chatterjee, S.K.; Bane, S.L.

Favourites:Add to Favourites

Optimization of a screening lead for factor VIIa/TF
pp. 2253-2256(4)
Authors: Young, W.B.; Kolesnikov, A.; Rai, R.; Sprengeler, P.A.; Leahy, E.M.; Shrader, W.D.; Sangalang, J.; Burgess-Henry, J.; Spencer, J.; Elrod, K.; Cregar, L.

Favourites:Add to Favourites

Modulation of immunostimulatory activity of CpG oligonucleotides by site-Specific deletion of nucleobases
pp. 2263-2267(5)
Authors: Yu, D.; Kandimalla, E.R.; Zhao, Q.; Cong, Y.; Agrawal, S.

Favourites:Add to Favourites

Antimalarial t-butylperoxyamines
pp. 2269-2272(4)
Authors: Sundar, N.; Jacob, V.T.; Bhat, S.V.; Valecha, N.; Biswas, S.

Favourites:Add to Favourites

Conformational search of antisense nucleotides
pp. 2273-2277(5)
Authors: Alcaro, S.; Tafi, A.; Ortuso, F.; Wozniak, L.A.; Gacs-Baitz, E.; Botta, M.

Favourites:Add to Favourites

Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors
pp. 2279-2282(4)
Authors: Su, T.; Wu, Y.; Doughan, B.; Kane-Maguire, K.; Marlowe, C.K.; Kanter, J.P.; Woolfrey, J.; Huang, B.; Wong, P.; Sinha, U.; Park, G.; Malinowski, J.; Hollenbach, S.; Scarborough, R.M.; Zhu, B.

Favourites:Add to Favourites

Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor
pp. 2283-2286(4)
Authors: Kordik, C.P.; Luo, C.; Zanoni, B.C.; Dax, S.L.; McNally, J.J.; Lovenberg, T.W.; Wilson, S.J.; Reitz, A.B.

Favourites:Add to Favourites

Pyrazolecarboxamide human neuropeptide Y5 receptor ligands with in vivo antifeedant activity
pp. 2287-2290(4)
Authors: Kordik, C.P.; Luo, C.; Zanoni, B.C.; Lovenberg, T.W.; Wilson, S.J.; Vaidya, A.H.; Crooke, J.J.; Rosenthal, D.I.; Reitz, A.B.

Favourites:Add to Favourites

Anti-AIDS agents. Part 47:?
pp. 2291-2293(3)
Authors: Xie, L.; Allaway, G.; Wild, C.; Kilgore, N.; Lee K.-H.

Favourites:Add to Favourites

Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings
pp. 2295-2300(6)
Authors: Ravi, G.; Lee, K.; Ji, X.; Kim, H.S.; Soltysiak, K.A.; Marquez, V.E.; Jacobson, K.A.

Favourites:Add to Favourites

Synthesis and biological evaluation of l- and d-configurations of 2',3'-dideoxy-4'-c-methyl-3'-oxacytidine analogues
pp. 2301-2304(4)
Authors: Liu, M.; Luo, M.; Mozdziesz, D.E.; Lin, T.; Dutschman, G.E.; Gullen, E.A.; Cheng, Y.; Sartorelli, A.C.

Favourites:Add to Favourites

Imidazolopyrazinones as potential antioxidants
pp. 2305-2309(5)
Authors: devillers, I.; Dive, G.; de Tollenaere, C.; Falmagne, B.; de Wergifosse, B.; Rees, J.; Marchand-Brynaert, J.

Favourites:Add to Favourites

Metabolic stabilization of benzylidene ketal M2 muscarinic receptor antagonists via halonaphthoic acid substitution
pp. 2311-2314(4)
Authors: Boyle, C.D.; Chackalamannil, S.; Clader, J.W.; Greenlee, W.J.; Josien, H.B.; Kaminski, J.J.; Kozlowski, J.A.; McCombie, S.W.; Nazareno, D.V.; Tagat, J.R.; Wang, Y.; Zhou, G.; Billard, W.; Binch, H.; Crosby, G.; Cohen-Williams, M.; Coffin, V.L.; Cox, K.A.; Grotz, D.E.; Duffy, R.A.; Ruperto, V.; Lachowicz, J.E.

Favourites:Add to Favourites

In vitro stability of α-Helical peptide nucleic acids (αPNAs)
pp. 2315-2317(3)
Authors: Garner, P.; Sherry, B.; Moilanen, S.; Huang, Y.

Favourites:Add to Favourites

A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (cpp): exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain
pp. 2319-2323(5)
Authors: Kawahata, N.; Yang, M.G.; Luke, G.P.; Shakespeare, W.C.; Sundaramoorthi, R.; Wang, Y.; Johnson, D.; Merry, T.; Violette, S.; Guan, W.; Bartlett, C.; Smith, J.; Hatada, M.; Lu, X.; Dalgarno, D.C.; Eyermann, C.J.; Bohacek, R.S.; Sawyer, T.K.

Favourites:Add to Favourites

Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors
pp. 2325-2330(6)
Authors: dener, J.M.; Wang, V.R.; Rice, K.D.; Gangloff, A.R.; Kuo, E.Y.; Newcomb, W.S.; Putnam, D.; Wong, M.

Favourites:Add to Favourites

Vinyl sulfonium as novel proteolytic enzyme inhibitor
pp. 2331-2335(5)
Authors: Zhao, G.; Zhou, Z.S.

Favourites:Add to Favourites

The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
pp. 2341-2343(3)
Authors: Flynn, B.L.; Flynn, G.P.; Hamel, E.; Jung, M.K.

Favourites:Add to Favourites

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D2-receptor and serotonin 5-HT1A-receptor affinities
pp. 2345-2349(5)
Authors: Feenstra, R.W.; de Moes, J.; Hofma, J.J.; Kling, H.; Kuipers, W.; Long, S.K.; Tulp, M.T.M.; van der Heyden, J.A.M.; Kruse, C.G.

Favourites:Add to Favourites

Parallel solid-Phase synthesis of zatebradine analogues as potential If channel blockers
pp. 2351-2354(4)
Authors: Bom, A.; Booth, S.; Bruin, J.; Clark, J.; Miller, S.; Wathey, B.

Favourites:Add to Favourites

Structure-activity relationship studies of a bisbenzimidazole-based, Zn2+-dependent inhibitor of HCV NS3 serine protease
pp. 2355-2359(5)
Authors: Yeung K.-S.; Meanwell, N.A.; Qiu, Z.; Hernandez, D.; Zhang, S.; McPhee, F.; Weinheimer, S.; Clark, J.M.; Janc, J.W.

Favourites:Add to Favourites

A novel class of inhibitors for steroid 5α-Reductase: synthesis and evaluation of umbelliferone derivatives
pp. 2361-2363(3)
Authors: Fan, G.; Mar, W.; Park, M.K.; Wook Choi, E.; Kim, K.; Kim, S.

Favourites:Add to Favourites

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist
pp. 2365-2367(3)
Authors: Fukunaga, K.; Tsukida, T.; Moriyama, H.; Kondo, H.

Favourites:Add to Favourites

Synthesis and bioactivities of novel pyridazine derivatives: inhibitors of interleukin-1 beta (IL-1) production
pp. 2369-2372(4)
Authors: Matsuda, T.; Aoki, T.; Ohgiya, T.; Koshi, T.; Ohkuchi, M.; Shigyo, H.

Favourites:Add to Favourites
Favourites:Add to Favourites

N-Hydroxyl derivatives of guanidine based drugs as enzymatic NO donors
pp. 2377-2380(4)
Authors: Xian, M.; Li, X.; Tang, X.; Chen, X.; Zheng, Z.; Galligan, J.J.; Kreulen, D.L.; Wang, P.G.

Favourites:Add to Favourites

3'-Azidoabscisic acid as a photoaffinity reagent for abscisic acid binding proteins
pp. 2381-2384(4)
Authors: Todoroki, Y.; Tanaka, T.; Kisamori, M.; Hirai, N.

Favourites:Add to Favourites

Identification of a series of oxadiazole-substituted α-isopropoxy phenylpropanoic acids with activity on PPARα, PPAR, and PPAR
pp. 2385-2388(4)
Authors: Liu, K.G.; Smith, J.S.; Ayscue, A.H.; Henke, B.R.; Lambert, M.H.; Leesnitzer, L.M.; Plunket, K.D.; Willson, T.M.; Sternbach, D.D.

Favourites:Add to Favourites

An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology
pp. 2393-2396(4)
Authors: deshpande, M.S.; Wei, J.; Luo, G.; Cianci, C.; Danetz, S.; Torri, A.; Tiley, L.; Krystal, M.; Yu, K.; Huang, S.; Gao, Q.; Meanwell, N.A.

Favourites:Add to Favourites

Synthesis and biological properties of new 1-methylcarbapenems containing heteroaromatic thioether moiety
pp. 2397-2399(3)
Authors: Shin, K.J.; Koo, K.D.; Yoo, K.H.; Kang, Y.K.; Park, S.W.; Kim, D.J.

Favourites:Add to Favourites

Hydrolysis of plasmid DNA catalyzed by Co(III) complex of cyclen attached to polystyrene
pp. 2401-2404(4)
Authors: Jeung, C.; Kim, C.H.; Min, K.; Suh, S.W.; Suh, J.

Favourites:Add to Favourites

Development of C-20 modified betulinic acid derivatives as antitumor agents
pp. 2405-2408(4)
Authors: Kim, J.Y.; Koo, H.; Kim, D.S.H.L.

Favourites:Add to Favourites

Corrigendum to ''conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity'': [Bioorg. Med. Chem. Lett. 11 (2001) 359]
pp. 2409-2409(1)
Authors: Tamamura, H.; Sugioka, M.; Odagaki, Y.; Omagari, A.; Kan, Y.; Oishi, S.; Nakashima, H.; Yamamoto, N.; Peiper, S.C.; Hamanaka, N.; Otaka, A.; Fujii, N.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more